GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adynxx Inc (FRA:HL1C) » Definitions » Cash And Cash Equivalents

Adynxx (FRA:HL1C) Cash And Cash Equivalents : €0.30 Mil (As of Sep. 2019)


View and export this data going back to 1998. Start your Free Trial

What is Adynxx Cash And Cash Equivalents?

Adynxx's quarterly cash and cash equivalents declined from Mar. 2019 (€6.84 Mil) to Jun. 2019 (€0.02 Mil) but then increased from Jun. 2019 (€0.02 Mil) to Sep. 2019 (€0.30 Mil).

Adynxx's annual cash and cash equivalents declined from Dec. 2016 (€5.29 Mil) to Dec. 2017 (€1.84 Mil) but then increased from Dec. 2017 (€1.84 Mil) to Dec. 2018 (€7.81 Mil).


Adynxx Cash And Cash Equivalents Historical Data

The historical data trend for Adynxx's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adynxx Cash And Cash Equivalents Chart

Adynxx Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.60 23.94 5.29 1.84 7.81

Adynxx Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.51 7.81 6.84 0.02 0.30

Adynxx Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Adynxx  (FRA:HL1C) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Adynxx Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Adynxx's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Adynxx (FRA:HL1C) Business Description

Industry
Traded in Other Exchanges
N/A
Address
100 Pine Street, Suite 500, San Francisco, CA, USA, 94111
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.

Adynxx (FRA:HL1C) Headlines

No Headlines